Correlation Between Inhibikase Therapeutics and Maravai Lifesciences
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Maravai Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Maravai Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Maravai Lifesciences Holdings, you can compare the effects of market volatilities on Inhibikase Therapeutics and Maravai Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Maravai Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Maravai Lifesciences.
Diversification Opportunities for Inhibikase Therapeutics and Maravai Lifesciences
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inhibikase and Maravai is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Maravai Lifesciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maravai Lifesciences and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Maravai Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maravai Lifesciences has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Maravai Lifesciences go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Maravai Lifesciences
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 1.42 times more return on investment than Maravai Lifesciences. However, Inhibikase Therapeutics is 1.42 times more volatile than Maravai Lifesciences Holdings. It trades about 0.0 of its potential returns per unit of risk. Maravai Lifesciences Holdings is currently generating about -0.14 per unit of risk. If you would invest 276.00 in Inhibikase Therapeutics on December 2, 2024 and sell it today you would lose (46.00) from holding Inhibikase Therapeutics or give up 16.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibikase Therapeutics vs. Maravai Lifesciences Holdings
Performance |
Timeline |
Inhibikase Therapeutics |
Maravai Lifesciences |
Inhibikase Therapeutics and Maravai Lifesciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibikase Therapeutics and Maravai Lifesciences
The main advantage of trading using opposite Inhibikase Therapeutics and Maravai Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Maravai Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maravai Lifesciences will offset losses from the drop in Maravai Lifesciences' long position.Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Maravai Lifesciences vs. Roivant Sciences | Maravai Lifesciences vs. Krystal Biotech | Maravai Lifesciences vs. Akero Therapeutics | Maravai Lifesciences vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |